Strategic Advisors LLC Gsk PLC Transaction History

Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 17, 2019	SELL	$40.46 - $43.52 $606,900 - $652,800	-15,000 Closed	0 $0
Q2 2019 Jul 22, 2019	SELL	$39.4 - $42.7 $78,800 - $85,400	-2,000 Reduced 11.76%	15,000 $600,000
Q1 2019 Apr 15, 2019	SELL	$38.57 - $42.69 $308,560 - $341,520	-8,000 Reduced 32.0%	17,000 $710,000
Q4 2018 Jan 24, 2019	SELL	$37.8 - $42.69 $132,300 - $149,415	-3,500 Reduced 12.28%	25,000 $955,000
Q3 2018 Oct 18, 2018	BUY	$39.75 - $42.69 $1.13 Million - $1.22 Million	28,500 New	28,500 $1.15 Million
Q4 2017 Jan 16, 2018	SELL	$35.34 - $41.9 $233,774 - $277,168	-6,615 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$39.44 - $41.55 $32,814 - $34,569	-832 Reduced 11.17%	6,615 $269,000
Q2 2017 Aug 10, 2017	BUY	N/A	7,447	7,447 $321,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Advisors LLC with notifications on news.